News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SCHEIBLER LUKAS
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/22/2023 |
4
| SCHEIBLER LUKAS (Chief Research Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 9,886 shares
@ $0
Paid exercise price by delivering 715 shares
@ $58.5, valued at
$41.8k
Granted 14,023 options to buy
@ $35.46, valued at
$497.3k
|
|
| 01/30/2023 |
4
| SCHEIBLER LUKAS (Chief Research Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 542 shares
@ $52.77, valued at
$28.6k
|
|
| 01/24/2023 |
4
| SCHEIBLER LUKAS (Chief Research Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,015 shares
@ $52.05, valued at
$104.9k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 609 shares
@ $60.087, valued at
$36.6k
Exercised 609 options to buy
@ $13.85, valued at
$8.4k
|
|
| 04/05/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 818 shares
@ $55.84, valued at
$45.7k
Sold 1,437 shares
@ $56.864, valued at
$81.7k
Sold 1,249 shares
@ $57.805, valued at
$72.2k
Exercised 3,504 options to buy
@ $13.85, valued at
$48.5k
|
|
| 04/04/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 11,496 shares
@ $55.05, valued at
$632.9k
Exercised 11,496 options to buy
@ $13.85, valued at
$159.2k
|
|
| 02/15/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 720 options to buy
@ $26.73, valued at
$19.2k
|
|
| 02/14/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 1,666 shares
@ $46.8, valued at
$78k
|
|
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 642 shares
@ $38.59, valued at
$24.8k
Sold 1,233 shares
@ $38.47, valued at
$47.4k
|
|
| 01/25/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 26,051 shares
@ $0
Granted 36,951 options to buy
@ $35.46, valued at
$1.3M
|
|
| 01/24/2022 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 3,021 options to buy
@ $26.73, valued at
$80.8k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| SCHEIBLER LUKAS (CHIEF INNOVATION OFFICER) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 7,482 options to buy
@ $26.73, valued at
$200k
|
|
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2018 |
4
| SCHEIBLER LUKAS (See Remarks) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 2,935 shares
@ $20.37, valued at
$59.8k
|
|
| 04/17/2018 |
4
| SCHEIBLER LUKAS (See Remarks) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 145,000 options to buy
@ $26.73, valued at
$3.9M
|
|
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|